The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming
Open accessAbstract
Summary One of the defining characteristics of a pre-metastatic niche, a fundamental requirement for primary tumor metastasis is infiltration of immunosuppressive macrophages. How these macrophages acquire their phenotype remains largely unexplored. Here, we demonstrate that tumor-derived exosomes (TDE) polarize macrophages towards an immunosuppressive phenotype characterized by increased PD-L1 expression through NF-kB-dependent, glycolytic dominant metabolic reprogramming. TDE signaling through TLR2 and NF-κB leads to increased glucose uptake. TDE also stimulate elevated NOS2 which inhibits mitochondrial oxidative phosphorylation resulting in increased conversion of pyruvate to lactate. Lactate feeds back on NF-κB further increasing PD-L1. Analysis of metastasis negative lymph nodes of non-small cell lung cancer patients revealed that macrophage PD-L1 positively correlates with levels of GLUT-1 and vesicle release gene YKT6 from primary tumors. Collectively, our study provides a novel mechanism by which macrophages within a pre-metastatic niche acquire their immunosuppressive phenotype and identifies an important link among exosomes, metabolism, and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, H., Zhang, H., Ge, S., Ning, T., Bai, M., Li, J., Li, S., Sun, W., Deng, T., Zhang, L., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.023 · Cited by 181
Self-citationRetractedAdverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Self-citationThe biology and management of non-small cell lung cancer
Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Chen, G., Huang, A. C., Zhang, W., Zhang, G., Wu, M., Xu, W., Yu, Z., Yang, J., Wang, B., Sun, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0392-8 · Cited by 2,813
Current knowledge on exosome biogenesis and release
Hessvik, N. P., & Llorente, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2595-9 · Cited by 2,362
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
The biology and function of exosomes in cancer
Kalluri, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81135 · Cited by 1,849
Methods for Staging Non-small Cell Lung Cancer
Silvestri, G. A., Gonzalez, A. V., Jantz, M. A., Margolis, M. L., Gould, M. K., Tanoue, L. T., Harris, L. J., & Detterbeck, F. C. (2013) · Chest · doi:10.1378/chest.12-2355 · Cited by 1,483
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Poggio, M., Hu, T., Pai, C.-C., Chu, B., Belair, C. D., Chang, A., Montabana, E., Lang, U. E., Fu, Q., Fong, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.016 · Cited by 1,376
Characteristics and Significance of the Pre-metastatic Niche
Liu, Y., & Cao, X. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.011 · Cited by 1,269
Novel Markers to Delineate Murine M1 and M2 Macrophages
Jablonski, K. A., Amici, S. A., Webb, L. M., Ruiz-Rosado, J. D. D., Popovich, P. G., Partida-Sanchez, S., & Guerau-de-Arellano, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145342 · Cited by 978
HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816
Lastwika, K. J., Wilson, W., Li, Q. K., Norris, J., Xu, H., Ghazarian, S. R., Kitagawa, H., Kawabata, S., Taube, J. M., Yao, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-3362 · Cited by 785
Liu, Y., Gu, Y., Han, Y., Zhang, Q., Jiang, Z., Zhang, X., Huang, B., Xu, X., Zheng, J., & Cao, X. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.021 · Cited by 640
Self-citationClinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
Theodoraki, M.-N., Yerneni, S. S., Hoffmann, T. K., Gooding, W. E., & Whiteside, T. L. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2664 · Cited by 624
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
Ricklefs, F. L., Alayo, Q., Krenzlin, H., Mahmoud, A. B., Speranza, M. C., Nakashima, H., Hayes, J. L., Lee, K., Balaj, L., Passaro, C., et al. (2018) · Science Advances · doi:10.1126/sciadv.aar2766 · Cited by 610
Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways
Huang, S., Rutkowsky, J. M., Snodgrass, R. G., Ono-Moore, K. D., Schneider, D. A., Newman, J. W., Adams, S. H., & Hwang, D. H. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d029546 · Cited by 592
Exosomes in bodily fluids are a highly stable resource of disease biomarkers
Boukouris, S., & Mathivanan, S. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400114 · Cited by 586
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Lin, H., Wei, S., Hurt, E. M., Green, M. D., Zhao, L., Vatan, L., Szeliga, W., Herbst, R., Harms, P. W., Fecher, L. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96113 · Cited by 584
Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells
Everts, B., Amiel, E., van der Windt, G. J. W., Freitas, T. C., Chott, R., Yarasheski, K. E., Pearce, E. L., & Pearce, E. J. (2012) · Blood · doi:10.1182/blood-2012-03-419747 · Cited by 532
PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
Tang, H., Liang, Y., Anders, R. A., Taube, J. M., Qiu, X., Mulgaonkar, A., Liu, X., Harrington, S. M., Guo, J., Xin, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96061 · Cited by 524
Atypical Pulmonary Metastases: Spectrum of Radiologic Findings
Seo, J. B., Im, J.-G., Goo, J. M., Chung, M. J., & Kim, M.-Y. (2001) · Radiographics · doi:10.1148/radiographics.21.2.g01mr17403 · Cited by 444
Visualization of immediate immune responses to pioneer metastatic cells in the lung
Headley, M. B., Bins, A., Nip, A., Roberts, E. W., Looney, M. R., Gerard, A., & Krummel, M. F. (2016) · Nature · doi:10.1038/nature16985 · Cited by 439
Isolation of Mouse Peritoneal Cavity Cells
Ray, A., & Dittel, B. N. (2010) · Journal of Visualized Experiments · doi:10.3791/1488 · Cited by 433
Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
Li, I., & Nabet, B. Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0975-5 · Cited by 416
Macrophages orchestrate breast cancer early dissemination and metastasis
Linde, N., Casanova-Acebes, M., Sosa, M. S., Mortha, A., Rahman, A., Farias, E., Harper, K., Tardio, E., Reyes Torres, I., Jones, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02481-5 · Cited by 413
Gabrusiewicz, K., Li, X., Wei, J., Hashimoto, Y., Marisetty, A. L., Ott, M., Wang, F., Hawke, D., Yu, J., Healy, L. M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1412909 · Cited by 348
Ludwig, S., Floros, T., Theodoraki, M.-N., Hong, C.-S., Jackson, E. K., Lang, S., & Whiteside, T. L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2819 · Cited by 334
Zhang, X., Shi, H., Yuan, X., Jiang, P., Qian, H., & Xu, W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0898-6 · Cited by 332
Self-citationImmune evasion before tumour invasion in early lung squamous carcinogenesis
Mascaux, C., Angelova, M., Vasaturo, A., Beane, J., Hijazi, K., Anthoine, G., Buttard, B., Rothe, F., Willard-Gallo, K., Haller, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1330-0 · Cited by 331
Zhang, X., Zeng, Y., Qu, Q., Zhu, J., Liu, Z., Ning, W., Zeng, H., Zhang, N., Du, W., Chen, C., et al. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1161-7 · Cited by 316
Self-citationApicella, M., Giannoni, E., Fiore, S., Ferrari, K. J., Fernández-Pérez, D., Isella, C., Granchi, C., Minutolo, F., Sottile, A., Comoglio, P. M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.006 · Cited by 299
Tumor-derived exosomes modulate PD-L1 expression in monocytes
Haderk, F., Schulz, R., Iskar, M., Cid, L. L., Worst, T., Willmund, K. V., Schulz, A., Warnken, U., Seiler, J., Benner, A., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aah5509 · Cited by 298
The Biodistribution and Immune Suppressive Effects of Breast Cancer–Derived Exosomes
Wen, S. W., Sceneay, J., Lima, L. G., Wong, C. S. F., Becker, M., Krumeich, S., Lobb, R. J., Castillo, V., Wong, K. N., Ellis, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0868 · Cited by 289
Exosomes promote pre-metastatic niche formation in ovarian cancer
Feng, W., Dean, D. C., Hornicek, F. J., Shi, H., & Duan, Z. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1049-4 · Cited by 289
Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis
Jeong, H., Kim, S., Hong, B.-J., Lee, C.-J., Kim, Y.-E., Bok, S., Oh, J.-M., Gwak, S.-H., Yoo, M. Y., Lee, M. S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2545 · Cited by 268
Gupta, S., Rawat, S., Arora, V., Kottarath, S. K., Dinda, A. K., Vaishnav, P. K., Nayak, B., & Mohanty, S. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0923-0 · Cited by 259
Penny, H. L., Sieow, J. L., Adriani, G., Yeap, W. H., See Chi Ee, P., San Luis, B., Lee, B., Lee, T., Mak, S. Y., Ho, Y. S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1191731 · Cited by 254
Bretz, N. P., Ridinger, J., Rupp, A.-K., Rimbach, K., Keller, S., Rupp, C., Marmé, F., Umansky, L., Umansky, V., Eigenbrod, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512806 · Cited by 245
Singhal, S., Stadanlick, J., Annunziata, M. J., Rao, A. S., Bhojnagarwala, P. S., O’Brien, S., Moon, E. K., Cantu, E., Danet-Desnoyers, G., Ra, H.-J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat1500 · Cited by 244
Hwang, D. H., Kim, J.-A., & Lee, J. Y. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.024 · Cited by 238
Melanoma exosomes promote mixed M1 and M2 macrophage polarization
Bardi, G. T., Smith, M. A., & Hood, J. L. (2018) · Cytokine · doi:10.1016/j.cyto.2018.02.002 · Cited by 235
Asgarova, A., Asgarov, K., Godet, Y., Peixoto, P., Nadaradjane, A., Boyer-Guittaut, M., Galaine, J., Guenat, D., Mougey, V., Perrard, J., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1423170 · Cited by 199
Bader, J. E., Enos, R. T., Velázquez, K. T., Carson, M. S., Nagarkatti, M., Nagarkatti, P. S., Chatzistamou, I., Davis, J. M., Carson, J. A., Robinson, C. M., et al. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00229.2017 · Cited by 168
c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
Lux, A., Kahlert, C., Grützmann, R., & Pilarsky, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133305 · Cited by 168
Nitric Oxide: The Forgotten Child of Tumor Metabolism
Rizi, B. S., Achreja, A., & Nagrath, D. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.07.005 · Cited by 149
Fleming, V., Hu, X., Weller, C., Weber, R., Groth, C., Riester, Z., Hüser, L., Sun, Q., Nagibin, V. S., Kirschning, C. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0053 · Cited by 145
Self-citationYKT6 expression, exosome release, and survival in non-small cell lung cancer
Ruíz-Martínez, M., Navarro, A., Marrades, R. M., Viñolas, N., Santasusagna, S., Muñoz, C., Ramírez, J., Molins, L., & Monzó, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9862 · Cited by 138
Wang, W. J., Chapman, N. M., Zhang, B., Li, M., Fan, M., Laribee, R. N., Zaidi, M. R., Pfeffer, L. M., Chi, H., & Wu, Z. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3134 · Cited by 130
Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications
Chin, A. R., & Wang, S. E. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0028 · Cited by 126
Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles
Muhsin-Sharafaldine, M.-R., Saunderson, S., Dunn, A. C., Faed, J., Kleffmann, T., & McLellan, A. (2016) · OncoTarget · doi:10.18632/oncotarget.10783 · Cited by 121
TLR2-Mediated Expansion of MDSCs Is Dependent on the Source of Tumor Exosomes
Xiang, X., Liu, Y., Zhuang, X., Zhang, S., Michalek, S., Taylor, D. D., Grizzle, W. E., & Zhang, H. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100245 · Cited by 84
Self-citationWu, L., & Yang, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.8215 · Cited by 73
Takada, K., Toyokawa, G., Yoneshima, Y., Tanaka, K., Okamoto, I., Shimokawa, M., Wakasu, S., Haro, A., Osoegawa, A., Tagawa, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50079-2 · Cited by 54
Aucott, H., Sowińska, A., Harris, H. E., & Lundbäck, P. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0021-x · Cited by 37
McGrath, K. M., Agarwal, S., Tonelli, M., Dergai, M., Gaeta, A. L., Shum, A. K., Lacoste, J., Zhang, Y., Wen, W., Chung, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016730118 · Cited by 26
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Metabolism, metabolites, and macrophages in cancer
Li, M., Yang, Y., Xiong, L., Jiang, P., Wang, J., & Li, C. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01478-6 · Cited by 507
NF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S.-C. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 489
Metadata
- Authors
- Morrissey, S. M., Zhang, F., Ding, C., Montoya-Durango, D. E., Hu, X., Yang, C., Wang, Z., Yuan, F., Fox, M., Zhang, H.-G., Guo, H., Tieri, D., Kong, M., Watson, C. T., Mitchell, R. A., Zhang, X., McMasters, K. M., Huang, J., & Yan, J.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 33
- Issue
- 10
- Pages
- 2040-2058.e10
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W3201325011
- Cited by
- 605
- References
- 66
- FWCI
- 26.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.